# Lexeo Therapeutics, Inc. Common Stock (LXEO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LXEO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -20.20M | $ -21.18M | $ 7.37M | $ 231.50M |
| 2025 | $ 0 | $ -102.35M | $ -101.32M | $ 7.89M | $ 246.67M |
| 2024 | $ 0 | $ -103.36M | $ -85.80M | $ 9.92M | $ 116.84M |
| 2023 | $ 0 | $ -71.79M | $ -64.51M | $ 11.64M | $ 113.54M |
| 2022 | $ 730.1K | $ -66.22M | $ -61.96M | $ 13.48M | $ -112.95M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.03 |
| Liabilities / Eq | 0.08 |
| Current Ratio | 14.16 |

## Other views

- [Metrics](https://sponda.capital/en/LXEO.md)
- [Charts](https://sponda.capital/en/LXEO/charts.md)
- [Compare](https://sponda.capital/en/LXEO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.